Literature DB >> 26173690

Rapid susceptibility testing for slowly growing nontuberculous mycobacteria using a colorimetric microbial viability assay based on the reduction of water-soluble tetrazolium WST-1.

T Tsukatani1, H Suenaga2, M Shiga3, T Ikegami3, M Ishiyama3, T Ezoe3, K Matsumoto4.   

Abstract

Rapid susceptibility testing for slowly growing nontuberculous mycobacteria (NTM) using a colorimetric microbial viability assay based on the reduction of the water-soluble tetrazolium salt {2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-1)} using 2,3,5,6-tetramethyl-1,4-benzoquinone as an electron mediator was developed. Using the Clinical and Laboratory Standards Institute (CLSI) method, a long-term incubation time (7-14 days) was required to determine the minimum inhibitory concentrations (MICs) of the slowly growing NTM. The MICs for a variety of different antibiotics against the slowly growing NTM were determined by the WST-1 colorimetric method and compared with those obtained using the broth microdilution methods approved by the CLSI. Good agreement was found between the MICs determined after 3-4 days using the WST-1 colorimetric method and those obtained after 10-14 days using the broth microdilution method. The results suggest that the WST-1 colorimetric assay is a useful method for the rapid determination of the MICs for the slowly growing NTM.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26173690     DOI: 10.1007/s10096-015-2438-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Colorimetric microbial viability assay based on reduction of water-soluble tetrazolium salts for antimicrobial susceptibility testing and screening of antimicrobial substances.

Authors:  Tadayuki Tsukatani; Tomoko Higuchi; Hikaru Suenaga; Tetsuyuki Akao; Munetaka Ishiyama; Takatoshi Ezoe; Kiyoshi Matsumoto
Journal:  Anal Biochem       Date:  2009-06-26       Impact factor: 3.365

2.  Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea.

Authors:  Y S Park; C-H Lee; S-M Lee; S-C Yang; C-G Yoo; Y W Kim; S K Han; Y-S Shim; J-J Yim
Journal:  Int J Tuberc Lung Dis       Date:  2010-08       Impact factor: 2.373

3.  Mycobacterium mucogenicum and other non-tuberculous mycobacteria in potable water of a trauma hospital: a potential source for human infection.

Authors:  E Fernandez-Rendon; J F Cerna-Cortes; M A Ramirez-Medina; A C Helguera-Repetto; S Rivera-Gutierrez; T Estrada-Garcia; J A Gonzalez-Y-Merchand
Journal:  J Hosp Infect       Date:  2011-11-04       Impact factor: 3.926

4.  Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey.

Authors:  Caroline Taillard; Gilbert Greub; Rainer Weber; Gaby E Pfyffer; Thomas Bodmer; Stefan Zimmerli; Reno Frei; Stefano Bassetti; Peter Rohner; Jean-Claude Piffaretti; Enos Bernasconi; Jacques Bille; Amalio Telenti; Guy Prod'hom
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Detection of microbial growth on polycyclic aromatic hydrocarbons in microtiter plates by using the respiration indicator WST-1.

Authors:  Anders R Johnsen; Karen Bendixen; Ulrich Karlson
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

6.  Emergence of disseminated infections due to nontuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan.

Authors:  Chih-Cheng Lai; Li-Na Lee; Liang-Wen Ding; Chong-Jen Yu; Po-Ren Hsueh; Pan-Chyr Yang
Journal:  J Infect       Date:  2005-11-28       Impact factor: 6.072

7.  Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study.

Authors:  J Mäkinen; M Marjamäki; M Haanperä-Heikkinen; H Marttila; L B Endourova; S E Presnova; V Mathys; P Bifani; R Ruohonen; M K Viljanen; H Soini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-11       Impact factor: 3.267

8.  Impact of non-tuberculous mycobacteria on pulmonary function decline in chronic obstructive pulmonary disease.

Authors:  C-T Huang; Y-J Tsai; H-D Wu; J-Y Wang; C-J Yu; L-N Lee; P-C Yang
Journal:  Int J Tuberc Lung Dis       Date:  2012-04       Impact factor: 2.373

9.  Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response.

Authors:  M T Henry; L Inamdar; D O'Riordain; M Schweiger; J P Watson
Journal:  Eur Respir J       Date:  2004-05       Impact factor: 16.671

10.  High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.

Authors:  Elisabeth Sanchez-Padilla; Themba Dlamini; Alexandra Ascorra; Sabine Rüsch-Gerdes; Zerihun Demissie Tefera; Philippe Calain; Roberto de la Tour; Frauke Jochims; Elvira Richter; Maryline Bonnet
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

View more
  3 in total

1.  Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival.

Authors:  Jibran Sualeh Muhammad; Khuloud Bajbouj; Jasmin Shafarin; Mawieh Hamad
Journal:  Epigenetics       Date:  2020-06-01       Impact factor: 4.528

2.  Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis.

Authors:  Xiao Jian Xi; Jin Jiang Zeng; Yong Lu; Shao Hua Chen; Zhi Wen Jiang; Peng Jie He; Hua Mi
Journal:  J Cell Mol Med       Date:  2020-05-22       Impact factor: 5.310

3.  Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents.

Authors:  Hui Pang; Yi Jiang; Kanglin Wan
Journal:  Biomed Res Int       Date:  2017-04-20       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.